Compound ID | 3292
Synonym(s): FND20081 | FNDR 20081
Class: Synthetic small molecule
Details of activity: | Active against Mycobacterium tuberculosis |
Description: | Synthetic compound; derivative of quinoline; shows no cytotoxicity (IC50) towards HepG2 and THP-1 cells at >100 uM |
Year first mentioned: | 2021 |
Highest developmental phase: | Preclinical |
Development status: | Experimental |
Chemical structure(s): | |
Canonical SMILES: | CC(C)C1=CC=C(C=C1)C2=NC(=NO2)CN3CCN(CC3)C4=CC=NC5=CC(=CC=C54)C6=CN=CC=C6 |
Isomeric SMILES: | CC(C)C1=CC=C(C=C1)C2=NC(=NO2)CN3CCN(CC3)C4=C5C=CC(=CC5=NC=C4)C6=CN=CC=C6 |
InChI: | InChI=1S/C30H30N6O/c1-21(2)22-5-7-23(8-6-22)30-33-29(34-37-30)20-35-14-16-36(17-15-35)28-11-13-32-27-18-24(9-10-26(27)28)25-4-3-12-31-19-25/h3-13,18-19,21H,14-17,20H2,1-2H3 |
InChI Key: | HIQQOKPODUCWTH-UHFFFAOYSA-N |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/146279269 |
External links: | |
Main Source: | https://www.sciencedirect.com/science/article/pii/S1472979221000548?via%3Dihub |
Citation: | https://www.sciencedirect.com/science/article/pii/S0960894X18308564 |